Dynavax Technologies | Lucro Operacional

Operating Profit Alterar Data
AbbVie USD 2.96B 233M 2024-03
Adma Biologics USD 21.82M 33.76M 2024-03
Amgen USD 991M 280M 2024-03
AstraZeneca USD 3.12B 1.88B 2024-03
Biogen USD 570M 211.1M 2024-03
BioMarin Pharmaceutical USD 78.46M 64.24M 2024-03
Bristol-Myers Squibb USD 1.51B 340M 2024-03
Dynavax Technologies USD -17769000 9.28M 2024-03
Gilead Sciences USD -191000000 1.8B 2024-03
Glaxosmithkline GBP 1.49B 917M 2024-03
Merck USD 5.76B 7.69B 2024-03
Neurocrine Biosciences USD 105.3M 35.9M 2024-03
Novartis USD 3.37B 791M 2024-03
Pfizer USD 4.2B 10.75B 2024-03
Regeneron Pharmaceuticals USD 758.5M 214.4M 2024-03
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD 34.9M 83.25M 2024-03
TG Therapeutics USD -9270000 3.22M 2024-03
Vertex Pharmaceuticals USD 1.22B 178.1M 2024-03



Dynavax Technologies Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.